Related Experiment Video
Updated: Jul 3, 2025

10:33
An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
Published on: February 3, 2023
1.3K
Emerging Roles of Small Extracellular Vesicles in Gastrointestinal Cancer Research and Therapy
Nora Schneider1, Patrick Christian Hermann1, Tim Eiseler1
1Department for Internal Medicine 1, University Clinic Ulm, 89081 Ulm, Germany.
Cancers
|February 10, 2024
Summary
Small extracellular vesicles (sEVs) are key mediators of intercellular communication, influencing cancer progression and immune responses. These nanovesicles offer novel avenues for GI-oncology diagnosis and treatment strategies.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Small extracellular vesicles (sEVs), initially viewed as cellular debris, are now recognized as crucial mediators of intercellular communication.
- These nanovesicles (30-150 nm) are secreted by cells and transfer proteins, RNAs, and lipids to recipient cells, influencing various biological processes.
Purpose of the Study:
- To review the multifaceted roles of sEVs in gastrointestinal (GI) oncology.
- To delineate the functions of sEVs in cancer progression, diagnosis, and therapeutic applications within GI cancers.
Main Methods:
- Literature review focusing on sEVs in GI-oncology.
- Analysis of sEVs' involvement in immune modulation, invasion, and pre-metastatic niche formation.
- Exploration of sEVs as biomarker platforms and therapeutic delivery systems.
Main Results:
- sEVs play significant roles in cancer progression, including immune modulation, pro-invasive signaling, and the formation of pre-metastatic niches.
- sEVs serve as ideal platforms for developing biomarkers for cancer diagnosis.
- Engineered sEVs show potential as drug carriers and components of anti-cancer vaccines.
Conclusions:
- sEVs represent a promising frontier for novel diagnostic and therapeutic strategies in GI oncology.
- Understanding sEV function is critical for harnessing their potential in cancer management.
Related Concept Videos
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Intralumenal Vesicles and Multivesicular Bodies
3.5K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.5K

